Jin Medical International Ltd.
ZJYL
$1.85
-$0.13-6.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -67.59% | -54.66% | -38.30% | -5.45% | 27.71% |
| Total Depreciation and Amortization | 1.33% | 17.00% | 36.41% | 43.97% | 53.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 185.92% | 135.35% | 57.14% | -14,221.43% | -252.51% |
| Change in Net Operating Assets | 122.27% | 104.17% | 69.54% | -105.66% | -2,350.10% |
| Cash from Operations | 340.48% | 629.73% | 215.88% | -97.24% | -138.87% |
| Capital Expenditure | -4,478.59% | -2,537.96% | -1,032.05% | -650.90% | -27.02% |
| Sale of Property, Plant, and Equipment | 0.00% | -96.30% | -100.00% | -98.06% | -96.08% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 60.91% | 24.26% | -49.93% | -33.08% | -22.85% |
| Cash from Investing | -13.43% | -42.08% | -98.80% | -52.11% | -23.08% |
| Total Debt Issued | 12.54% | 47.82% | 107.86% | 140.63% | 198.00% |
| Total Debt Repaid | -108.01% | -91.24% | -75.07% | -34.35% | 5.53% |
| Issuance of Common Stock | -- | -100.00% | -100.00% | -96.53% | -96.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -36.91% | 8.71% | 119.13% | 89.37% | 68.64% |
| Foreign Exchange rate Adjustments | -151.02% | -540.48% | 80.40% | 159.80% | 282.40% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -155.89% | 13.25% | 1,082.91% | 48.79% | -43.54% |